Research & Clinical Trials

Evaluation of Belatacept as First-line Immunosuppression in De Novo Liver Transplant Recipients (IM 103-045) - Closed to Enrollment
Principal Investigator: James Spivey, MD
Study Coordinator: Faith Burnett, RN

Immune Monitoring and Assay Development in Organ Transplant Recipients - Enrolling
Principal Investigator: Allan D. Kirk, MD, PhD
Study Coordinator: Shine Thomas, CRC

The Influence of Conjugated Hyperbilirubinemia on Pulse Oximetric Accuracy in Liver Disease - Enrolling
Principal Investigator: Ram Subramanian, MD
Study Coordinator: Elizabeth Ferry, RN

The Safety of Using MRI with Gadolinium in Patients with Liver Disease - Retrospective Review
Principal Investigator: Ram Subramanian, MD
Study Coordinator: Elizabeth Ferry, RN

The Safety of Using MRI with Gadolinium in ICU Patients - Retrospective Review
Principal Investigator: Ram Subramanian, MD
Study Coordinator: Elizabeth Ferry, RN

A Multi-Center, Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type-I with Leucassin (Terlipressin) - Reverse Trial
Principal Investigator: Ram Subramanian, MD
Study Coordinator: Hernando Avila, CRC, Elizabeth Ferry, RN

If you are interested in learning more about these or other Emory Transplant Center Clinical Research projects, please call the ETC Clinical Research Program at 404-712-1114 to speak with one of our research coordinators.

Emory Transplant Center